SWOG clinical trial number
SWOG-9040

Intergroup Rectal Adjuvant Protocol, A Phase III Study

Closed
Phase
Published
Abbreviated Title
Intergroup Rectal Adjuvant Protocol, A Phase III Study
Activated
09/15/1990
Closed
11/22/1992

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

2002

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of Intergroup 0114

JE Tepper;M O'Connell;D Niedzwiecki;DR Hollis;AB Benson III;B Cummings;LL Gunderson;JS Macdonald;JA Martenson;RJ Mayer Journal of Clinical Oncology 20(7):1744-1750

2001

Impact of number of nodes retrieved on outcome in patients with rectal cancer.

JE Tepper;MJ O'Connell;D Niedzwiecki;D Hollis;C Compton;AB Benson III;B Cummings;L Gunderson;JS Macdonald;RJ Mayer Journal of Clinical Oncology 19(1):157-163

Impact of TNM stage on survival and disease control in adjuvant rectal cancer pooled analysis

LL Gunderson;DJ Sargent;J Tepper;M J O'Connell;C Allmer;SR Smalley;JA Martenson;DG Haller;R Mayer;TA Rich Int J Radiat Oncol Biol Phys 51(3):8-9(#10)

1997

Adjuvant postoperative fluorouracil modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of intergroup 0114.

JE Tepper;MJ O'Connell;GR Petroni;D Hollis;E Cooke;AB Benson III;B Cummings;LL Gunderson;JS Macdonald;JA Martenson Journal of Clinical Oncology 15(5):2030-2039

1996

Toxicity in the adjuvant therapy of rectal cancer: A preliminary report of Intergropu 0114 (CALGB 9081).

J Teppper;M O'Connell;G Petroni;A Benson;J Macdonald;J Martenson;T Rich;H Stern American Society of Clinical Oncology 15:210(#481)

Other Clinical Trials

SWOG Clinical Trial Number
S2303

Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS ≥ 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)
Research Committee(s)
Gastrointestinal Cancer
Activated
05/06/2024
Open
SWOG Clinical Trial Number
CTSU/A022101

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
SWOG Clinical Trial Number
S2107

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
Accrual
83%
Open
Phase